• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含乳酸菌和双歧杆菌的酸奶补充剂对幽门螺杆菌根除三联疗法的影响。

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.

作者信息

Sheu B-S, Wu J-J, Lo C-Y, Wu H-W, Chen J-H, Lin Y-S, Lin M-D

机构信息

Department of Internal Medicine, Medical College, National Cheng Kung University, Tainan, Taiwan.

出版信息

Aliment Pharmacol Ther. 2002 Sep;16(9):1669-75. doi: 10.1046/j.1365-2036.2002.01335.x.

DOI:10.1046/j.1365-2036.2002.01335.x
PMID:12197847
Abstract

AIM

To test whether supplements of Lactobacillus- and Bifidobacterium-containing yogurt (AB-Yogurt) affect the success of Helicobacter pylori eradication.

METHODS

One hundred and sixty H. pylori-infected patients were randomized into a triple-plus-yogurt group or a triple-only group, receiving 1 week of triple therapy with and without supplements of AB-Yogurt, respectively. In the triple-plus-yogurt group, AB-Yogurt was continued for 4 weeks after triple therapy. Eight weeks later, patients were assessed for the success of H. pylori eradication. The stool samples of 22 randomly selected patients, 11 from each group, were provided on enrolment, at the first week and at the fifth week for evaluation of the percentage of Bifidobacterium in anaerobes.

RESULTS

By intention-to-treat analysis, the triple-plus-yogurt group had a higher H. pylori eradication rate than the triple-only group (91% vs. 78%, P < 0.05). The per protocol H. pylori eradication rates were similar for both groups (93.5% vs. 89%, P = N.S.). Only patients supplemented with AB-Yogurt showed restoration of the percentage of Bifidobacterium in the anaerobes of stools at the fifth week to the level in the stools on enrolment.

CONCLUSIONS

Supplement with AB-Yogurt can improve the intention-to-treat eradication rates of H. pylori, and can restore the depletion of Bifidobacterium in stools after triple therapy.

摘要

目的

检测含乳酸杆菌和双歧杆菌的酸奶(AB酸奶)补充剂是否会影响幽门螺杆菌根除的成功率。

方法

160例幽门螺杆菌感染患者被随机分为三联疗法加酸奶组或单纯三联疗法组,分别接受为期1周的含或不含AB酸奶补充剂的三联疗法。在三联疗法加酸奶组中,三联疗法后继续服用AB酸奶4周。8周后,评估患者幽门螺杆菌根除的成功率。在入组时、第1周和第5周,从每组中随机选取11例患者,共22例患者提供粪便样本,以评估厌氧菌中双歧杆菌的百分比。

结果

意向性分析显示,三联疗法加酸奶组的幽门螺杆菌根除率高于单纯三联疗法组(91%对78%,P<0.05)。两组的符合方案分析的幽门螺杆菌根除率相似(93.5%对89%,P=无统计学意义)。只有补充AB酸奶的患者在第5周时粪便厌氧菌中双歧杆菌的百分比恢复到入组时粪便中的水平。

结论

补充AB酸奶可提高意向性分析的幽门螺杆菌根除率,并可恢复三联疗法后粪便中双歧杆菌的减少。

相似文献

1
Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.含乳酸菌和双歧杆菌的酸奶补充剂对幽门螺杆菌根除三联疗法的影响。
Aliment Pharmacol Ther. 2002 Sep;16(9):1669-75. doi: 10.1046/j.1365-2036.2002.01335.x.
2
Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy.干酪乳杆菌 OLL2716 预处理对一线幽门螺杆菌根除治疗的影响。
J Gastroenterol Hepatol. 2012 May;27(5):888-92. doi: 10.1111/j.1440-1746.2011.06985.x.
3
The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.益生菌对质子泵抑制剂三联疗法根除幽门螺杆菌的影响。
Helicobacter. 2008 Aug;13(4):261-8. doi: 10.1111/j.1523-5378.2008.00601.x.
4
Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy.用含乳酸杆菌和双歧杆菌的酸奶进行预处理,可以提高四联疗法根除三联疗法失败后残留幽门螺杆菌感染的疗效。
Am J Clin Nutr. 2006 Apr;83(4):864-9. doi: 10.1093/ajcn/83.4.864.
5
Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.在兰索拉唑 - 阿莫西林 - 甲硝唑三联疗法中添加维生素C和E补充剂可能会降低对甲硝唑敏感的幽门螺杆菌感染的根除率。
Helicobacter. 2002 Oct;7(5):310-6. doi: 10.1046/j.1523-5378.2002.00095.x.
6
Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.益生菌能否提高幽门螺杆菌三联根除疗法的有效性和安全性?一项前瞻性随机研究。
Vojnosanit Pregl. 2016 Nov;73(11):1044-9. doi: 10.2298/VSP150415127G.
7
The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.慢性肾功能不全患者根除幽门螺杆菌的三联疗法选择
Aliment Pharmacol Ther. 2003 May 15;17(10):1283-90. doi: 10.1046/j.1365-2036.2003.01527.x.
8
Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.在泰国,通过添加铋剂和益生菌补充剂改善标准三联疗法对幽门螺杆菌的根除率。
Asian Pac J Cancer Prev. 2014;15(22):9909-13. doi: 10.7314/apjcp.2014.15.22.9909.
9
Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.德氏乳杆菌和嗜热链球菌预处理对幽门螺杆菌根除个体化三联疗法的影响:一项前瞻性随机对照临床试验
Asian Pac J Cancer Prev. 2015;16(12):4885-90. doi: 10.7314/apjcp.2015.16.12.4885.
10
Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.补充维生素 C 和 E 以增强标准三联疗法根除幽门螺杆菌。
J Clin Pharm Ther. 2012 Jun;37(3):282-5. doi: 10.1111/j.1365-2710.2011.01286.x. Epub 2011 Jul 11.

引用本文的文献

1
Bifidobacteria in Fermented Dairy Foods: A Health Beneficial Outlook.发酵乳制品中的双歧杆菌:有益健康的展望。
Probiotics Antimicrob Proteins. 2025 Jun;17(3):1-22. doi: 10.1007/s12602-023-10189-w. Epub 2023 Nov 18.
2
A Systematic Review and Meta-analysis of Randomized Clinical Trials on the Prevention and Treatment of Pouchitis after Ileoanal Pouch Anastomosis.经肛门直肠吻合术后 pouchitis 的预防和治疗的随机临床试验的系统评价和荟萃分析。
J Gastrointest Surg. 2023 Nov;27(11):2650-2660. doi: 10.1007/s11605-023-05841-3. Epub 2023 Oct 10.
3
Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis.
不同益生菌补充剂对三联幽门螺杆菌根除效果的比较:网络荟萃分析。
Front Cell Infect Microbiol. 2023 May 15;13:1120789. doi: 10.3389/fcimb.2023.1120789. eCollection 2023.
4
Gastric microbiota: an emerging player in gastric cancer.胃微生物群:胃癌中一个新出现的因素
Front Microbiol. 2023 Apr 27;14:1130001. doi: 10.3389/fmicb.2023.1130001. eCollection 2023.
5
Efficacy and safety of bifidobacterium quadruple viable tablets in the treatment of Helicobacter pylori-infected peptic ulcer or gastritis patients: a systematic review and meta-analysis.双歧四联活菌片治疗幽门螺杆菌感染消化性溃疡或胃炎患者的疗效和安全性:系统评价和荟萃分析。
BMC Infect Dis. 2023 May 9;23(1):313. doi: 10.1186/s12879-023-08211-1.
6
Gut microbiome alterations in ICU patients with enteral nutrition-related diarrhea.患有肠内营养相关性腹泻的重症监护病房患者的肠道微生物群改变
Front Microbiol. 2022 Nov 22;13:1051687. doi: 10.3389/fmicb.2022.1051687. eCollection 2022.
7
Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections.益生菌作为对抗幽门螺杆菌胃部感染的活体微生物战士。
BMC Gastroenterol. 2021 Oct 20;21(1):388. doi: 10.1186/s12876-021-01977-1.
8
The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives.胃肠道癌症的细菌微生物群:在癌症发病机制中的作用及治疗前景
Clin Exp Gastroenterol. 2020 May 6;13:151-185. doi: 10.2147/CEG.S243337. eCollection 2020.
9
Probiotic and strains possess safety characteristics, antiviral activities and host adherence factors revealed by genome mining.益生菌及其菌株具有通过基因组挖掘揭示的安全特性、抗病毒活性和宿主黏附因子。
EPMA J. 2019 Sep 5;10(4):337-350. doi: 10.1007/s13167-019-00184-z. eCollection 2019 Dec.
10
Effects of anti-H. pylori triple therapy and a probiotic complex on intestinal microbiota in duodenal ulcer.抗幽门螺杆菌三联疗法和益生菌复合制剂对十二指肠溃疡肠道微生物群的影响。
Sci Rep. 2019 Sep 6;9(1):12874. doi: 10.1038/s41598-019-49415-3.